Repligen (Germany) Today
| RGN Stock | EUR 141.40 1.55 1.11% |
PerformanceFair
| Odds Of DistressLow
|
Repligen is trading at 141.40 as of the 13th of January 2026. This is a 1.11% increase since the beginning of the trading day. The stock's lowest day price was 141.4. Repligen has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat fair performance during the last 90 days. The performance scores are derived for the period starting the 14th of December 2025 and ending today, the 13th of January 2026. Click here to learn more.
Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally. The company was founded in 1981 and is headquartered in Waltham, Massachusetts. The company has 55.56 M outstanding shares. More on Repligen
Moving against Repligen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Repligen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Repligen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Repligen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Repligen (RGN) is traded on Frankfurt Exchange in Germany and employs 2,025 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.53 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Repligen's market, we take the total number of its shares issued and multiply it by Repligen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Repligen classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 55.56 M outstanding shares.
Repligen has accumulated about 196.14 M in cash with 172.08 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.15.
Check Repligen Probability Of Bankruptcy
Ownership AllocationRepligen owns a total of 55.56 Million outstanding shares. The majority of Repligen outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Repligen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Repligen. Please pay attention to any change in the institutional holdings of Repligen as this could imply that something significant has changed or is about to change at the company. Also note that almost two million five hundred thirty-nine thousand two hundred eleven invesors are currently shorting Repligen expressing very little confidence in its future performance.
Check Repligen Ownership Details
Repligen Risk Profiles
Although Repligen's alpha and beta are two of the key measurements used to evaluate Repligen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.81 | |||
| Semi Deviation | 1.95 | |||
| Standard Deviation | 2.31 | |||
| Variance | 5.33 |
Repligen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Repligen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Repligen Corporate Management
Elected by the shareholders, the Repligen's board of directors comprises two types of representatives: Repligen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Repligen. The board's role is to monitor Repligen's management team and ensure that shareholders' interests are well served. Repligen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Repligen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christine Gebski | VP Chromatography | Profile | |
| Kimberly Cornwell | Global Counsel | Profile | |
| James Bylund | Chief Officer | Profile | |
| Sondra Newman | Global Relations | Profile | |
| Stephen Tingley | VP Sales | Profile | |
| Anthony Hunt | CEO Pres | Profile | |
| Jon Snodgres | Chief Officer | Profile |
Additional Information and Resources on Investing in Repligen Stock
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in Repligen Stock please use our How to Invest in Repligen guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.